PlainPharmaWatch

CMS Open Payments · Program Year 2024

Dompe US, Inc.

Dompe US, Inc. reported $1,730,522.98 across General Payments, Research, and Ownership to 11,308 physicians and teaching hospitals across 11,319 transactions.

See the rankings → How this is sourced
$1.7M
All-tracks total
11,319
Transactions
11,308
Recipients
+$213.3K
General Payments vs PY2023

Dompe US, Inc. reported $1,730,522.98 across all CMS Open Payments tracks (General + Research + Ownership) to 11,308 physicians and teaching hospitals in Program Year 2024 - ranking #484 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,253,071.89, averaging $153.04 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer dompe-us-inc Dompe US, Inc.

$1.7M · #484/1,925 · 0.0% industry · PY2024

  • TOT $1.7M
  • RANK #484
  • SHARE 0.0%
  • TXN 11,319
  • RCP 11,308
  • CAT 7
  • GEN $1.3M
  • ΔGEN +$213.3K
  • TOP1 5.6%
  • PY 2024

Volume peers

Nearest volume peer: Y-mAbs Therapeutics, Inc. ($1.7M)

Radiometer America, Inc$1.7MDompe US, Inc. (this)$1.7MY-mAbs Therapeutics, Inc.$1.7MPharmacosmos Therapeutics In…$1.7MEsperion Therapeutics, Inc.$1.7M
All-tracks payment totals near Dompe US, Inc. (CMS Open Payments PY2024)

Dompe US, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Dompe US, Inc.'s CMS-reported General Payments increased by $213.3K (+20.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: DOMPE US, INC.PY2023: DOMPE US, INC.PY2024: Dompe US, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.0MPY2024$1.3M
PY2023
$1,039,788.77
PY2024
$1,253,071.89

What the Data Shows for Dompe US, Inc.

$1,730,522.98: that is what Dompe US, Inc. reported in payments to 11,308 physicians and teaching hospitals during Program Year 2024, spread across 11,319 transactions ($152.89 per transaction, $153.04 per recipient). The company sits at rank #484 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Faculty or Speaker (Medical Education)" at $463.0K, accounting for 36.9% of this company's General Payments and 178 transactions.

General Payment Breakdown by Type

Dompe US, Inc. made 7 types of general payments. "Compensation for Faculty or Speaker (Medical Education)" is the largest category at $463.0K, 36.9% of General Payments.

Dompe US, Inc. reports 7 general-payment categories - the top three are Compensation for Faculty or Speaker (Medical Education) (36.9%), Food and Beverage (35.6%), and Consulting Fee (15.3%). The remaining 4 categories make up 12.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Dompe US, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Compensation for Faculty …$463.0K2. Food and Beverage$446.3K3. Consulting Fee$192.0K4. Travel and Lodging$114.8K5. Grant$20.0K6. Charitable Contribution$15.0K7. Education$2.0K
Payment Type Amount Transactions
Compensation for Faculty or Speaker (Medical Education) $463.0K 178
Food and Beverage $446.3K 10,589
Consulting Fee $192.0K 60
Travel and Lodging $114.8K 421
Grant $20.0K 2
Charitable Contribution $15.0K 1
Education $2.0K 57

Recipient Concentration in General Payments

The five largest recipient relationships account for $201,670.24 (16.1%) of $1,253,071.89 in this company's General Payments records across 7,050 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Dompe US, Inc.

The five named recipients with the highest reported General Payments from this company

John Affeldt$70.3KNishi Shah$49.2KTimothy Poirier$28.3KPedram Hamrah$27.6KJohn Sheppard$26.3K
  1. 1

    John Affeldt

    $70,250.84 across 115 reported transactions

  2. 2

    Nishi Shah

    $49,186.92 across 113 reported transactions

  3. 3

    Timothy Poirier

    $28,256.39 across 68 reported transactions

  4. 4

    Pedram Hamrah

    $27,643.18 across 8 reported transactions

  5. 5

    John Sheppard

    $26,332.91 across 27 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Dompe US, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Dompe US, Inc..

ADC Therapeutics America, Inc.

HHI 111

Avion Pharmaceuticals

HHI 112

Kyowa Kirin, Inc.

HHI 111

Travere Therapeutics, Inc.

HHI 112

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Dompe US, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Dompe US, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.